{"entity":{"type":"insider","cik":"0001446989","url":"/insider/0001446989","json_url":"/insider/0001446989.json","name":"Ullem Scott B.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":69,"n_filings":43,"first":"2018-03-30","last":"2026-04-09","span_basis":"filed_date"},"name_variants":[{"name":"Ullem Scott B.","source":"filing","n_filings":43,"first_seen":"2018-03-30","last_seen":"2026-04-09"}],"transactions":[{"id":5931312,"accession":"0001225208-26-004476","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001225208-26-004476","line_url":"/filing/0001225208-26-004476","is_derivative":false,"issuer_cik":"0001099800","issuer_name":"Edwards Lifesciences Corp","issuer_ticker":"EW","issuer_name_source":null,"issuer_url":"/issuer/0001099800","owner_cik":"0001446989","owner_name":"Ullem Scott B.","owner_display_name":"Ullem Scott B.","owner_url":"/insider/0001446989","role":"Officer (CVP, Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (CVP, Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CVP, Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13000.0,"shares_display":"13,000","price_per_share":80.04187363076923,"price_display":"80.04","price_state":"stated","total_value":1040544.3572,"total_display":"1,040,544.36","total_whole":"1,040,544","shares_owned_after":39699.0,"shares_owned_after_display":"39,699","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-04-09","filed_date":"2026-04-09","scope":"insider","n_lines":2},{"id":5774706,"accession":"0001225208-26-003539","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001225208-26-003539","line_url":"/filing/0001225208-26-003539","is_derivative":false,"issuer_cik":"0001099800","issuer_name":"Edwards Lifesciences Corp","issuer_ticker":"EW","issuer_name_source":null,"issuer_url":"/issuer/0001099800","owner_cik":"0001446989","owner_name":"Ullem Scott B.","owner_display_name":"Ullem Scott B.","owner_url":"/insider/0001446989","role":"Officer (CVP, Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (CVP, Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CVP, Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13000.0,"shares_display":"13,000","price_per_share":84.9150605076923,"price_display":"84.92","price_state":"stated","total_value":1103895.7866,"total_display":"1,103,895.79","total_whole":"1,103,896","shares_owned_after":39699.0,"shares_owned_after_display":"39,699","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-11","filed_date":"2026-03-11","scope":"insider","n_lines":2},{"id":4493485,"accession":"0001225208-25-009797","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001225208-25-009797","line_url":"/filing/0001225208-25-009797#line-2","is_derivative":false,"issuer_cik":"0001099800","issuer_name":"Edwards Lifesciences Corp","issuer_ticker":"EW","issuer_name_source":null,"issuer_url":"/issuer/0001099800","owner_cik":"0001446989","owner_name":"Ullem Scott B.","owner_display_name":"Ullem Scott B.","owner_url":"/insider/0001446989","role":"Officer (CVP, Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (CVP, Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CVP, Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7700.0,"shares_display":"7,700","price_per_share":84.4691,"price_display":"84.47","price_state":"stated","total_value":650412.07,"total_display":"650,412.07","total_whole":"650,412","shares_owned_after":39898.0,"shares_owned_after_display":"39,898","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-12-09","filed_date":"2025-12-09","scope":"insider"},{"id":4848651,"accession":"0001225208-25-009067","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001225208-25-009067","line_url":"/filing/0001225208-25-009067","is_derivative":false,"issuer_cik":"0001099800","issuer_name":"Edwards Lifesciences Corp","issuer_ticker":"EW","issuer_name_source":null,"issuer_url":"/issuer/0001099800","owner_cik":"0001446989","owner_name":"Ullem Scott B.","owner_display_name":"Ullem Scott B.","owner_url":"/insider/0001446989","role":"Officer (CVP, Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (CVP, Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CVP, Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13000.0,"shares_display":"13,000","price_per_share":83.08410963076923,"price_display":"83.08","price_state":"stated","total_value":1080093.4252,"total_display":"1,080,093.43","total_whole":"1,080,093","shares_owned_after":39898.0,"shares_owned_after_display":"39,898","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-11-10","filed_date":"2025-11-10","scope":"insider","n_lines":2},{"id":5144824,"accession":"0001225208-25-004942","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001225208-25-004942","line_url":"/filing/0001225208-25-004942#line-4","is_derivative":false,"issuer_cik":"0001099800","issuer_name":"Edwards Lifesciences Corp","issuer_ticker":"EW","issuer_name_source":null,"issuer_url":"/issuer/0001099800","owner_cik":"0001446989","owner_name":"Ullem Scott B.","owner_display_name":"Ullem Scott B.","owner_url":"/insider/0001446989","role":"Officer (CVP, Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (CVP, Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CVP, Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11250.0,"shares_display":"11,250","price_per_share":74.4031,"price_display":"74.40","price_state":"stated","total_value":837034.875,"total_display":"837,034.88","total_whole":"837,035","shares_owned_after":41098.0,"shares_owned_after_display":"41,098","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-05-09","filed_date":"2025-05-09","scope":"insider"},{"id":4586225,"accession":"0001225208-25-003654","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001225208-25-003654","line_url":"/filing/0001225208-25-003654#line-2","is_derivative":false,"issuer_cik":"0001099800","issuer_name":"Edwards Lifesciences Corp","issuer_ticker":"EW","issuer_name_source":null,"issuer_url":"/issuer/0001099800","owner_cik":"0001446989","owner_name":"Ullem Scott B.","owner_display_name":"Ullem Scott B.","owner_url":"/insider/0001446989","role":"Officer (CVP, Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (CVP, Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CVP, Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11250.0,"shares_display":"11,250","price_per_share":70.8682,"price_display":"70.87","price_state":"stated","total_value":797267.25,"total_display":"797,267.25","total_whole":"797,267","shares_owned_after":30387.0,"shares_owned_after_display":"30,387","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-26","filed_date":"2025-03-26","scope":"insider"},{"id":4848090,"accession":"0001225208-25-002619","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001225208-25-002619","line_url":"/filing/0001225208-25-002619","is_derivative":false,"issuer_cik":"0001099800","issuer_name":"Edwards Lifesciences Corp","issuer_ticker":"EW","issuer_name_source":null,"issuer_url":"/issuer/0001099800","owner_cik":"0001446989","owner_name":"Ullem Scott B.","owner_display_name":"Ullem Scott B.","owner_url":"/insider/0001446989","role":"Officer (CVP, Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (CVP, Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CVP, Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11250.0,"shares_display":"11,250","price_per_share":70.78462142222222,"price_display":"70.78","price_state":"stated","total_value":796326.991,"total_display":"796,326.99","total_whole":"796,327","shares_owned_after":30387.0,"shares_owned_after_display":"30,387","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-28","filed_date":"2025-02-28","scope":"insider","n_lines":2},{"id":5184998,"accession":"0001225208-25-001712","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001225208-25-001712","line_url":"/filing/0001225208-25-001712#line-2","is_derivative":false,"issuer_cik":"0001099800","issuer_name":"Edwards Lifesciences Corp","issuer_ticker":"EW","issuer_name_source":null,"issuer_url":"/issuer/0001099800","owner_cik":"0001446989","owner_name":"Ullem Scott B.","owner_display_name":"Ullem Scott B.","owner_url":"/insider/0001446989","role":"Officer (CVP, Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (CVP, Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CVP, Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11250.0,"shares_display":"11,250","price_per_share":75.7575,"price_display":"75.76","price_state":"stated","total_value":852271.875,"total_display":"852,271.88","total_whole":"852,272","shares_owned_after":30561.0,"shares_owned_after_display":"30,561","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-13","filed_date":"2025-02-13","scope":"insider"},{"id":2520206,"accession":"0001225208-24-010647","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001225208-24-010647","line_url":"/filing/0001225208-24-010647#line-2","is_derivative":false,"issuer_cik":"0001099800","issuer_name":"Edwards Lifesciences Corp","issuer_ticker":"EW","issuer_name_source":null,"issuer_url":"/issuer/0001099800","owner_cik":"0001446989","owner_name":"Ullem Scott B.","owner_display_name":"Ullem Scott B.","owner_url":"/insider/0001446989","role":"Officer (CVP, Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (CVP, Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CVP, Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11250.0,"shares_display":"11,250","price_per_share":71.6805,"price_display":"71.68","price_state":"stated","total_value":806405.625,"total_display":"806,405.62","total_whole":"806,406","shares_owned_after":30561.0,"shares_owned_after_display":"30,561","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-12-09","filed_date":"2024-12-09","scope":"insider"},{"id":2038492,"accession":"0001225208-24-006925","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001225208-24-006925","line_url":"/filing/0001225208-24-006925","is_derivative":false,"issuer_cik":"0001099800","issuer_name":"Edwards Lifesciences Corp","issuer_ticker":"EW","issuer_name_source":null,"issuer_url":"/issuer/0001099800","owner_cik":"0001446989","owner_name":"Ullem Scott B.","owner_display_name":"Ullem Scott B.","owner_url":"/insider/0001446989","role":"Officer (CVP, Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (CVP, Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CVP, Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5625.0,"shares_display":"5,625","price_per_share":87.51253066666666,"price_display":"87.51","price_state":"stated","total_value":492257.985,"total_display":"492,257.98","total_whole":"492,258","shares_owned_after":30561.0,"shares_owned_after_display":"30,561","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-06-20","filed_date":"2024-06-20","scope":"insider","n_lines":2},{"id":2153139,"accession":"0001225208-24-006287","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001225208-24-006287","line_url":"/filing/0001225208-24-006287#line-2","is_derivative":false,"issuer_cik":"0001099800","issuer_name":"Edwards Lifesciences Corp","issuer_ticker":"EW","issuer_name_source":null,"issuer_url":"/issuer/0001099800","owner_cik":"0001446989","owner_name":"Ullem Scott B.","owner_display_name":"Ullem Scott B.","owner_url":"/insider/0001446989","role":"Officer (CVP, Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (CVP, Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CVP, Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5625.0,"shares_display":"5,625","price_per_share":90.4539,"price_display":"90.45","price_state":"stated","total_value":508803.1875,"total_display":"508,803.19","total_whole":"508,803","shares_owned_after":30561.0,"shares_owned_after_display":"30,561","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-05-21","filed_date":"2024-05-21","scope":"insider"},{"id":2361383,"accession":"0001225208-24-005397","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001225208-24-005397","line_url":"/filing/0001225208-24-005397","is_derivative":false,"issuer_cik":"0001099800","issuer_name":"Edwards Lifesciences Corp","issuer_ticker":"EW","issuer_name_source":null,"issuer_url":"/issuer/0001099800","owner_cik":"0001446989","owner_name":"Ullem Scott B.","owner_display_name":"Ullem Scott B.","owner_url":"/insider/0001446989","role":"Officer (CVP, Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (CVP, Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CVP, Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7250.0,"shares_display":"7,250","price_per_share":85.8016324137931,"price_display":"85.80","price_state":"stated","total_value":622061.835,"total_display":"622,061.84","total_whole":"622,062","shares_owned_after":19074.0,"shares_owned_after_display":"19,074","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-04-30","filed_date":"2024-04-30","scope":"insider","n_lines":2},{"id":3173266,"accession":"0001225208-24-004692","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001225208-24-004692","line_url":"/filing/0001225208-24-004692","is_derivative":false,"issuer_cik":"0001099800","issuer_name":"Edwards Lifesciences Corp","issuer_ticker":"EW","issuer_name_source":null,"issuer_url":"/issuer/0001099800","owner_cik":"0001446989","owner_name":"Ullem Scott B.","owner_display_name":"Ullem Scott B.","owner_url":"/insider/0001446989","role":"Officer (CVP, Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (CVP, Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CVP, Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7255.0,"shares_display":"7,255","price_per_share":94.88952341833219,"price_display":"94.89","price_state":"stated","total_value":688423.4924,"total_display":"688,423.49","total_whole":"688,423","shares_owned_after":19074.0,"shares_owned_after_display":"19,074","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-04-01","filed_date":"2024-04-01","scope":"insider","n_lines":2},{"id":2853841,"accession":"0001225208-24-003305","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001225208-24-003305","line_url":"/filing/0001225208-24-003305#line-2","is_derivative":false,"issuer_cik":"0001099800","issuer_name":"Edwards Lifesciences Corp","issuer_ticker":"EW","issuer_name_source":null,"issuer_url":"/issuer/0001099800","owner_cik":"0001446989","owner_name":"Ullem Scott B.","owner_display_name":"Ullem Scott B.","owner_url":"/insider/0001446989","role":"Officer (CVP, Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (CVP, Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CVP, Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7255.0,"shares_display":"7,255","price_per_share":85.5855,"price_display":"85.59","price_state":"stated","total_value":620922.8025,"total_display":"620,922.80","total_whole":"620,923","shares_owned_after":19074.0,"shares_owned_after_display":"19,074","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-29","filed_date":"2024-02-29","scope":"insider"},{"id":2643264,"accession":"0001225208-24-001384","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001225208-24-001384","line_url":"/filing/0001225208-24-001384#line-2","is_derivative":false,"issuer_cik":"0001099800","issuer_name":"Edwards Lifesciences Corp","issuer_ticker":"EW","issuer_name_source":null,"issuer_url":"/issuer/0001099800","owner_cik":"0001446989","owner_name":"Ullem Scott B.","owner_display_name":"Ullem Scott B.","owner_url":"/insider/0001446989","role":"Officer (CVP, Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (CVP, Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CVP, Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7255.0,"shares_display":"7,255","price_per_share":78.29,"price_display":"78.29","price_state":"stated","total_value":567993.95,"total_display":"567,993.95","total_whole":"567,994","shares_owned_after":19248.0,"shares_owned_after_display":"19,248","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-01","filed_date":"2024-02-01","scope":"insider"},{"id":7873808,"accession":"0001225208-23-011362","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001225208-23-011362","line_url":"/filing/0001225208-23-011362#line-2","is_derivative":false,"issuer_cik":"0001099800","issuer_name":"Edwards Lifesciences Corp","issuer_ticker":"EW","issuer_name_source":null,"issuer_url":"/issuer/0001099800","owner_cik":"0001446989","owner_name":"Ullem Scott B.","owner_display_name":"Ullem Scott B.","owner_url":"/insider/0001446989","role":"Officer (CVP, Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (CVP, Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CVP, Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14510.0,"shares_display":"14,510","price_per_share":76.5537,"price_display":"76.55","price_state":"stated","total_value":1110794.187,"total_display":"1,110,794.19","total_whole":"1,110,794","shares_owned_after":19248.0,"shares_owned_after_display":"19,248","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-12-29","filed_date":"2023-12-29","scope":"insider"},{"id":8514206,"accession":"0001225208-23-009845","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001225208-23-009845","line_url":"/filing/0001225208-23-009845#line-2","is_derivative":false,"issuer_cik":"0001099800","issuer_name":"Edwards Lifesciences Corp","issuer_ticker":"EW","issuer_name_source":null,"issuer_url":"/issuer/0001099800","owner_cik":"0001446989","owner_name":"Ullem Scott B.","owner_display_name":"Ullem Scott B.","owner_url":"/insider/0001446989","role":"Officer (CVP, Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (CVP, Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CVP, Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7255.0,"shares_display":"7,255","price_per_share":62.6559,"price_display":"62.66","price_state":"stated","total_value":454568.5545,"total_display":"454,568.55","total_whole":"454,569","shares_owned_after":19248.0,"shares_owned_after_display":"19,248","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-10-31","filed_date":"2023-10-31","scope":"insider"},{"id":8381644,"accession":"0001225208-23-009087","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001225208-23-009087","line_url":"/filing/0001225208-23-009087#line-2","is_derivative":false,"issuer_cik":"0001099800","issuer_name":"Edwards Lifesciences Corp","issuer_ticker":"EW","issuer_name_source":null,"issuer_url":"/issuer/0001099800","owner_cik":"0001446989","owner_name":"Ullem Scott B.","owner_display_name":"Ullem Scott B.","owner_url":"/insider/0001446989","role":"Officer (CVP, Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (CVP, Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CVP, Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7255.0,"shares_display":"7,255","price_per_share":69.542,"price_display":"69.54","price_state":"stated","total_value":504527.21,"total_display":"504,527.21","total_whole":"504,527","shares_owned_after":19248.0,"shares_owned_after_display":"19,248","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-09-29","filed_date":"2023-09-29","scope":"insider"},{"id":8260419,"accession":"0001225208-23-008596","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001225208-23-008596","line_url":"/filing/0001225208-23-008596#line-2","is_derivative":false,"issuer_cik":"0001099800","issuer_name":"Edwards Lifesciences Corp","issuer_ticker":"EW","issuer_name_source":null,"issuer_url":"/issuer/0001099800","owner_cik":"0001446989","owner_name":"Ullem Scott B.","owner_display_name":"Ullem Scott B.","owner_url":"/insider/0001446989","role":"Officer (CVP, Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (CVP, Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CVP, Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7255.0,"shares_display":"7,255","price_per_share":77.79,"price_display":"77.79","price_state":"stated","total_value":564366.45,"total_display":"564,366.45","total_whole":"564,366","shares_owned_after":19248.0,"shares_owned_after_display":"19,248","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-08-31","filed_date":"2023-08-31","scope":"insider"},{"id":8708782,"accession":"0001225208-23-007787","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001225208-23-007787","line_url":"/filing/0001225208-23-007787#line-2","is_derivative":false,"issuer_cik":"0001099800","issuer_name":"Edwards Lifesciences Corp","issuer_ticker":"EW","issuer_name_source":null,"issuer_url":"/issuer/0001099800","owner_cik":"0001446989","owner_name":"Ullem Scott B.","owner_display_name":"Ullem Scott B.","owner_url":"/insider/0001446989","role":"Officer (CVP, Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (CVP, Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CVP, Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7255.0,"shares_display":"7,255","price_per_share":84.35,"price_display":"84.35","price_state":"stated","total_value":611959.25,"total_display":"611,959.25","total_whole":"611,959","shares_owned_after":19248.0,"shares_owned_after_display":"19,248","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-07-31","filed_date":"2023-07-31","scope":"insider"},{"id":8635859,"accession":"0001225208-23-007036","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001225208-23-007036","line_url":"/filing/0001225208-23-007036#line-2","is_derivative":false,"issuer_cik":"0001099800","issuer_name":"Edwards Lifesciences Corp","issuer_ticker":"EW","issuer_name_source":null,"issuer_url":"/issuer/0001099800","owner_cik":"0001446989","owner_name":"Ullem Scott B.","owner_display_name":"Ullem Scott B.","owner_url":"/insider/0001446989","role":"Officer (CVP, Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (CVP, Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CVP, Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7255.0,"shares_display":"7,255","price_per_share":93.27,"price_display":"93.27","price_state":"stated","total_value":676673.85,"total_display":"676,673.85","total_whole":"676,674","shares_owned_after":19248.0,"shares_owned_after_display":"19,248","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-30","filed_date":"2023-06-30","scope":"insider"},{"id":8755162,"accession":"0001225208-23-005755","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001225208-23-005755","line_url":"/filing/0001225208-23-005755","is_derivative":false,"issuer_cik":"0001099800","issuer_name":"Edwards Lifesciences Corp","issuer_ticker":"EW","issuer_name_source":null,"issuer_url":"/issuer/0001099800","owner_cik":"0001446989","owner_name":"Ullem Scott B.","owner_display_name":"Ullem Scott B.","owner_url":"/insider/0001446989","role":"Officer (CVP, Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (CVP, Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CVP, Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":80700.0,"shares_display":"80,700","price_per_share":88.5378434535316,"price_display":"88.54","price_state":"stated","total_value":7145003.9667,"total_display":"7,145,003.97","total_whole":"7,145,004","shares_owned_after":18294.0,"shares_owned_after_display":"18,294","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-05-10","filed_date":"2023-05-11","scope":"insider","n_lines":2},{"id":2916134,"accession":"0001225208-20-012745","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001225208-20-012745","line_url":"/filing/0001225208-20-012745","is_derivative":false,"issuer_cik":"0001099800","issuer_name":"Edwards Lifesciences Corp","issuer_ticker":"EW","issuer_name_source":null,"issuer_url":"/issuer/0001099800","owner_cik":"0001446989","owner_name":"Ullem Scott B.","owner_display_name":"Ullem Scott B.","owner_url":"/insider/0001446989","role":"Officer (CVP, Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (CVP, Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CVP, Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":33150.0,"shares_display":"33,150","price_per_share":78.80510112217195,"price_display":"78.81","price_state":"stated","total_value":2612389.1022,"total_display":"2,612,389.10","total_whole":"2,612,389","shares_owned_after":27114.0,"shares_owned_after_display":"27,114","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-10-26","filed_date":"2020-10-26","scope":"insider","n_lines":2},{"id":2600526,"accession":"0001225208-20-012447","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001225208-20-012447","line_url":"/filing/0001225208-20-012447","is_derivative":false,"issuer_cik":"0001099800","issuer_name":"Edwards Lifesciences Corp","issuer_ticker":"EW","issuer_name_source":null,"issuer_url":"/issuer/0001099800","owner_cik":"0001446989","owner_name":"Ullem Scott B.","owner_display_name":"Ullem Scott B.","owner_url":"/insider/0001446989","role":"Officer (CVP, Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (CVP, Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CVP, Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":33150.0,"shares_display":"33,150","price_per_share":83.80744298642534,"price_display":"83.81","price_state":"stated","total_value":2778216.735,"total_display":"2,778,216.74","total_whole":"2,778,217","shares_owned_after":27114.0,"shares_owned_after_display":"27,114","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-10-12","filed_date":"2020-10-13","scope":"insider","n_lines":2},{"id":2448366,"accession":"0001225208-20-011862","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001225208-20-011862","line_url":"/filing/0001225208-20-011862#line-2","is_derivative":false,"issuer_cik":"0001099800","issuer_name":"Edwards Lifesciences Corp","issuer_ticker":"EW","issuer_name_source":null,"issuer_url":"/issuer/0001099800","owner_cik":"0001446989","owner_name":"Ullem Scott B.","owner_display_name":"Ullem Scott B.","owner_url":"/insider/0001446989","role":"Officer (CVP, Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (CVP, Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CVP, Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":33150.0,"shares_display":"33,150","price_per_share":78.1057,"price_display":"78.11","price_state":"stated","total_value":2589203.955,"total_display":"2,589,203.96","total_whole":"2,589,204","shares_owned_after":27114.0,"shares_owned_after_display":"27,114","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-09-28","filed_date":"2020-09-28","scope":"insider"},{"id":2567967,"accession":"0001225208-20-011594","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001225208-20-011594","line_url":"/filing/0001225208-20-011594#line-2","is_derivative":false,"issuer_cik":"0001099800","issuer_name":"Edwards Lifesciences Corp","issuer_ticker":"EW","issuer_name_source":null,"issuer_url":"/issuer/0001099800","owner_cik":"0001446989","owner_name":"Ullem Scott B.","owner_display_name":"Ullem Scott B.","owner_url":"/insider/0001446989","role":"Officer (CVP, Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (CVP, Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CVP, Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":33150.0,"shares_display":"33,150","price_per_share":83.4313,"price_display":"83.43","price_state":"stated","total_value":2765747.595,"total_display":"2,765,747.60","total_whole":"2,765,748","shares_owned_after":27114.0,"shares_owned_after_display":"27,114","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-09-15","filed_date":"2020-09-15","scope":"insider"},{"id":2902440,"accession":"0001225208-20-011538","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001225208-20-011538","line_url":"/filing/0001225208-20-011538#line-2","is_derivative":false,"issuer_cik":"0001099800","issuer_name":"Edwards Lifesciences Corp","issuer_ticker":"EW","issuer_name_source":null,"issuer_url":"/issuer/0001099800","owner_cik":"0001446989","owner_name":"Ullem Scott B.","owner_display_name":"Ullem Scott B.","owner_url":"/insider/0001446989","role":"Officer (CVP, Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (CVP, Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CVP, Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":26700.0,"shares_display":"26,700","price_per_share":82.2063,"price_display":"82.21","price_state":"stated","total_value":2194908.21,"total_display":"2,194,908.21","total_whole":"2,194,908","shares_owned_after":27114.0,"shares_owned_after_display":"27,114","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-09-14","filed_date":"2020-09-14","scope":"insider"},{"id":2482210,"accession":"0001225208-20-010370","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001225208-20-010370","line_url":"/filing/0001225208-20-010370#line-2","is_derivative":false,"issuer_cik":"0001099800","issuer_name":"Edwards Lifesciences Corp","issuer_ticker":"EW","issuer_name_source":null,"issuer_url":"/issuer/0001099800","owner_cik":"0001446989","owner_name":"Ullem Scott B.","owner_display_name":"Ullem Scott B.","owner_url":"/insider/0001446989","role":"Officer (CVP, Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (CVP, Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CVP, Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":26700.0,"shares_display":"26,700","price_per_share":77.3067,"price_display":"77.31","price_state":"stated","total_value":2064088.89,"total_display":"2,064,088.89","total_whole":"2,064,089","shares_owned_after":27114.0,"shares_owned_after_display":"27,114","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-08-06","filed_date":"2020-08-06","scope":"insider"},{"id":2086492,"accession":"0001225208-20-009652","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001225208-20-009652","line_url":"/filing/0001225208-20-009652#line-2","is_derivative":false,"issuer_cik":"0001099800","issuer_name":"Edwards Lifesciences Corp","issuer_ticker":"EW","issuer_name_source":null,"issuer_url":"/issuer/0001099800","owner_cik":"0001446989","owner_name":"Ullem Scott B.","owner_display_name":"Ullem Scott B.","owner_url":"/insider/0001446989","role":"Officer (CVP, Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (CVP, Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CVP, Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":26700.0,"shares_display":"26,700","price_per_share":69.9771,"price_display":"69.98","price_state":"stated","total_value":1868388.57,"total_display":"1,868,388.57","total_whole":"1,868,389","shares_owned_after":27114.0,"shares_owned_after_display":"27,114","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-07-06","filed_date":"2020-07-06","scope":"insider"},{"id":2600321,"accession":"0001225208-20-009143","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001225208-20-009143","line_url":"/filing/0001225208-20-009143","is_derivative":false,"issuer_cik":"0001099800","issuer_name":"Edwards Lifesciences Corp","issuer_ticker":"EW","issuer_name_source":null,"issuer_url":"/issuer/0001099800","owner_cik":"0001446989","owner_name":"Ullem Scott B.","owner_display_name":"Ullem Scott B.","owner_url":"/insider/0001446989","role":"Officer (CVP, Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (CVP, Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CVP, Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":26700.0,"shares_display":"26,700","price_per_share":69.51043067041199,"price_display":"69.51","price_state":"stated","total_value":1855928.4989,"total_display":"1,855,928.50","total_whole":"1,855,928","shares_owned_after":27114.0,"shares_owned_after_display":"27,114","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-22","filed_date":"2020-06-22","scope":"insider","n_lines":2},{"id":2661267,"accession":"0001225208-20-000615","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001225208-20-000615","line_url":"/filing/0001225208-20-000615#line-2","is_derivative":false,"issuer_cik":"0001099800","issuer_name":"Edwards Lifesciences Corp","issuer_ticker":"EW","issuer_name_source":null,"issuer_url":"/issuer/0001099800","owner_cik":"0001446989","owner_name":"Ullem Scott B.","owner_display_name":"Ullem Scott B.","owner_url":"/insider/0001446989","role":"Officer (CVP, Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (CVP, Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CVP, Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7500.0,"shares_display":"7,500","price_per_share":234.25,"price_display":"234.25","price_state":"stated","total_value":1756875.0,"total_display":"1,756,875.00","total_whole":"1,756,875","shares_owned_after":9938.0,"shares_owned_after_display":"9,938","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-01-07","filed_date":"2020-01-07","scope":"insider"},{"id":8126275,"accession":"0001225208-19-015604","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001225208-19-015604","line_url":"/filing/0001225208-19-015604#line-2","is_derivative":false,"issuer_cik":"0001099800","issuer_name":"Edwards Lifesciences Corp","issuer_ticker":"EW","issuer_name_source":null,"issuer_url":"/issuer/0001099800","owner_cik":"0001446989","owner_name":"Ullem Scott B.","owner_display_name":"Ullem Scott B.","owner_url":"/insider/0001446989","role":"Officer (CVP, Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (CVP, Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CVP, Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7500.0,"shares_display":"7,500","price_per_share":233.88,"price_display":"233.88","price_state":"stated","total_value":1754100.0,"total_display":"1,754,100.00","total_whole":"1,754,100","shares_owned_after":9938.0,"shares_owned_after_display":"9,938","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-12-10","filed_date":"2019-12-10","scope":"insider"},{"id":7893476,"accession":"0001225208-19-014404","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001225208-19-014404","line_url":"/filing/0001225208-19-014404#line-2","is_derivative":false,"issuer_cik":"0001099800","issuer_name":"Edwards Lifesciences Corp","issuer_ticker":"EW","issuer_name_source":null,"issuer_url":"/issuer/0001099800","owner_cik":"0001446989","owner_name":"Ullem Scott B.","owner_display_name":"Ullem Scott B.","owner_url":"/insider/0001446989","role":"Officer (CVP, Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (CVP, Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CVP, Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7500.0,"shares_display":"7,500","price_per_share":234.28,"price_display":"234.28","price_state":"stated","total_value":1757100.0,"total_display":"1,757,100.00","total_whole":"1,757,100","shares_owned_after":9938.0,"shares_owned_after_display":"9,938","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-11-12","filed_date":"2019-11-12","scope":"insider"},{"id":8423095,"accession":"0001225208-19-013933","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001225208-19-013933","line_url":"/filing/0001225208-19-013933#line-4","is_derivative":false,"issuer_cik":"0001099800","issuer_name":"Edwards Lifesciences Corp","issuer_ticker":"EW","issuer_name_source":null,"issuer_url":"/issuer/0001099800","owner_cik":"0001446989","owner_name":"Ullem Scott B.","owner_display_name":"Ullem Scott B.","owner_url":"/insider/0001446989","role":"Officer (CVP, Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (CVP, Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CVP, Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7500.0,"shares_display":"7,500","price_per_share":235.3,"price_display":"235.30","price_state":"stated","total_value":1764750.0,"total_display":"1,764,750.00","total_whole":"1,764,750","shares_owned_after":9938.0,"shares_owned_after_display":"9,938","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-10-29","filed_date":"2019-10-30","scope":"insider"},{"id":8522620,"accession":"0001225208-19-012275","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001225208-19-012275","line_url":"/filing/0001225208-19-012275#line-2","is_derivative":false,"issuer_cik":"0001099800","issuer_name":"Edwards Lifesciences Corp","issuer_ticker":"EW","issuer_name_source":null,"issuer_url":"/issuer/0001099800","owner_cik":"0001446989","owner_name":"Ullem Scott B.","owner_display_name":"Ullem Scott B.","owner_url":"/insider/0001446989","role":"Officer (CVP, Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (CVP, Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CVP, Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7500.0,"shares_display":"7,500","price_per_share":225.74,"price_display":"225.74","price_state":"stated","total_value":1693050.0,"total_display":"1,693,050.00","total_whole":"1,693,050","shares_owned_after":13564.0,"shares_owned_after_display":"13,564","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-09-09","filed_date":"2019-09-09","scope":"insider"},{"id":8302494,"accession":"0001225208-19-011904","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001225208-19-011904","line_url":"/filing/0001225208-19-011904#line-2","is_derivative":false,"issuer_cik":"0001099800","issuer_name":"Edwards Lifesciences Corp","issuer_ticker":"EW","issuer_name_source":null,"issuer_url":"/issuer/0001099800","owner_cik":"0001446989","owner_name":"Ullem Scott B.","owner_display_name":"Ullem Scott B.","owner_url":"/insider/0001446989","role":"Officer (CVP, Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (CVP, Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CVP, Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7500.0,"shares_display":"7,500","price_per_share":213.44,"price_display":"213.44","price_state":"stated","total_value":1600800.0,"total_display":"1,600,800.00","total_whole":"1,600,800","shares_owned_after":13564.0,"shares_owned_after_display":"13,564","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-08-26","filed_date":"2019-08-26","scope":"insider"},{"id":6458466,"accession":"0001225208-18-013252","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001225208-18-013252","line_url":"/filing/0001225208-18-013252","is_derivative":false,"issuer_cik":"0001099800","issuer_name":"Edwards Lifesciences Corp","issuer_ticker":"EW","issuer_name_source":null,"issuer_url":"/issuer/0001099800","owner_cik":"0001446989","owner_name":"Ullem Scott B.","owner_display_name":"Ullem Scott B.","owner_url":"/insider/0001446989","role":"Officer (CVP, CFO)","role_mark":"O","role_mark_label":"Officer (CVP, CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CVP, CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25036.0,"shares_display":"25,036","price_per_share":140.04264703626777,"price_display":"140.04","price_state":"stated","total_value":3506107.7112,"total_display":"3,506,107.71","total_whole":"3,506,108","shares_owned_after":15983.0,"shares_owned_after_display":"15,983","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-09-05","filed_date":"2018-09-07","scope":"insider","n_lines":3}],"collapsed":true,"next_cursor":"2018-09-05|6458460","ledger_fault":false,"count":{"value":69,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":69,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":69},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001099800","name":"Edwards Lifesciences Corp","url":"/issuer/0001099800","role":"Officer (CVP, Chief Financial Officer)","n_filings":43,"first_seen":"2018-03-30","last_seen":"2026-04-09"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001446989","retrieved_at":"2026-08-22T21:52:39+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}